Global Drugs for Malaria Market Growth (Status and Outlook) 2025-2031

December 2024 | 96 pages | ID: G393A32D3076EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Drugs for Malaria market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

LPI (LP Information)' newest research report, the “Drugs for Malaria Industry Forecast” looks at past sales and reviews total world Drugs for Malaria sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Malaria sales for 2025 through 2031. With Drugs for Malaria sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Malaria industry.

This Insight Report provides a comprehensive analysis of the global Drugs for Malaria landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs for Malaria portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Malaria market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Malaria and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Malaria.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Segmentation by Application:

• Prevention
• Treatment
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Malaria Market Size (2020-2031)
  2.1.2 Drugs for Malaria Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Drugs for Malaria by Country/Region (2020, 2024 & 2031)
2.2 Drugs for Malaria Segment by Type
  2.2.1 Aryl Aminoalcohol Compounds
  2.2.2 Antifolate Compounds
  2.2.3 Artemisinin Compounds
2.3 Drugs for Malaria Market Size by Type
  2.3.1 Drugs for Malaria Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Drugs for Malaria Market Size Market Share by Type (2020-2025)
2.4 Drugs for Malaria Segment by Application
  2.4.1 Prevention
  2.4.2 Treatment
  2.4.3 Others
2.5 Drugs for Malaria Market Size by Application
  2.5.1 Drugs for Malaria Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Drugs for Malaria Market Size Market Share by Application (2020-2025)

3 DRUGS FOR MALARIA MARKET SIZE BY PLAYER

3.1 Drugs for Malaria Market Size Market Share by Player
  3.1.1 Global Drugs for Malaria Revenue by Player (2020-2025)
  3.1.2 Global Drugs for Malaria Revenue Market Share by Player (2020-2025)
3.2 Global Drugs for Malaria Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DRUGS FOR MALARIA BY REGION

4.1 Drugs for Malaria Market Size by Region (2020-2025)
4.2 Global Drugs for Malaria Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drugs for Malaria Market Size Growth (2020-2025)
4.4 APAC Drugs for Malaria Market Size Growth (2020-2025)
4.5 Europe Drugs for Malaria Market Size Growth (2020-2025)
4.6 Middle East & Africa Drugs for Malaria Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Drugs for Malaria Market Size by Country (2020-2025)
5.2 Americas Drugs for Malaria Market Size by Type (2020-2025)
5.3 Americas Drugs for Malaria Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs for Malaria Market Size by Region (2020-2025)
6.2 APAC Drugs for Malaria Market Size by Type (2020-2025)
6.3 APAC Drugs for Malaria Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Drugs for Malaria Market Size by Country (2020-2025)
7.2 Europe Drugs for Malaria Market Size by Type (2020-2025)
7.3 Europe Drugs for Malaria Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Malaria by Region (2020-2025)
8.2 Middle East & Africa Drugs for Malaria Market Size by Type (2020-2025)
8.3 Middle East & Africa Drugs for Malaria Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DRUGS FOR MALARIA MARKET FORECAST

10.1 Global Drugs for Malaria Forecast by Region (2026-2031)
  10.1.1 Global Drugs for Malaria Forecast by Region (2026-2031)
  10.1.2 Americas Drugs for Malaria Forecast
  10.1.3 APAC Drugs for Malaria Forecast
  10.1.4 Europe Drugs for Malaria Forecast
  10.1.5 Middle East & Africa Drugs for Malaria Forecast
10.2 Americas Drugs for Malaria Forecast by Country (2026-2031)
  10.2.1 United States Market Drugs for Malaria Forecast
  10.2.2 Canada Market Drugs for Malaria Forecast
  10.2.3 Mexico Market Drugs for Malaria Forecast
  10.2.4 Brazil Market Drugs for Malaria Forecast
10.3 APAC Drugs for Malaria Forecast by Region (2026-2031)
  10.3.1 China Drugs for Malaria Market Forecast
  10.3.2 Japan Market Drugs for Malaria Forecast
  10.3.3 Korea Market Drugs for Malaria Forecast
  10.3.4 Southeast Asia Market Drugs for Malaria Forecast
  10.3.5 India Market Drugs for Malaria Forecast
  10.3.6 Australia Market Drugs for Malaria Forecast
10.4 Europe Drugs for Malaria Forecast by Country (2026-2031)
  10.4.1 Germany Market Drugs for Malaria Forecast
  10.4.2 France Market Drugs for Malaria Forecast
  10.4.3 UK Market Drugs for Malaria Forecast
  10.4.4 Italy Market Drugs for Malaria Forecast
  10.4.5 Russia Market Drugs for Malaria Forecast
10.5 Middle East & Africa Drugs for Malaria Forecast by Region (2026-2031)
  10.5.1 Egypt Market Drugs for Malaria Forecast
  10.5.2 South Africa Market Drugs for Malaria Forecast
  10.5.3 Israel Market Drugs for Malaria Forecast
  10.5.4 Turkey Market Drugs for Malaria Forecast
10.6 Global Drugs for Malaria Forecast by Type (2026-2031)
10.7 Global Drugs for Malaria Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Drugs for Malaria Forecast

11 KEY PLAYERS ANALYSIS

11.1 Cipla
  11.1.1 Cipla Company Information
  11.1.2 Cipla Drugs for Malaria Product Offered
  11.1.3 Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Cipla Main Business Overview
  11.1.5 Cipla Latest Developments
11.2 Guilin Pharmaceutical
  11.2.1 Guilin Pharmaceutical Company Information
  11.2.2 Guilin Pharmaceutical Drugs for Malaria Product Offered
  11.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Guilin Pharmaceutical Main Business Overview
  11.2.5 Guilin Pharmaceutical Latest Developments
11.3 IPCA Laboratories
  11.3.1 IPCA Laboratories Company Information
  11.3.2 IPCA Laboratories Drugs for Malaria Product Offered
  11.3.3 IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 IPCA Laboratories Main Business Overview
  11.3.5 IPCA Laboratories Latest Developments
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Company Information
  11.4.2 GlaxoSmithKline Drugs for Malaria Product Offered
  11.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline Main Business Overview
  11.4.5 GlaxoSmithKline Latest Developments
11.5 Mylan Labs
  11.5.1 Mylan Labs Company Information
  11.5.2 Mylan Labs Drugs for Malaria Product Offered
  11.5.3 Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mylan Labs Main Business Overview
  11.5.5 Mylan Labs Latest Developments
11.6 Roche
  11.6.1 Roche Company Information
  11.6.2 Roche Drugs for Malaria Product Offered
  11.6.3 Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Roche Main Business Overview
  11.6.5 Roche Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Drugs for Malaria Product Offered
  11.7.3 Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 Sanofi Aventis
  11.8.1 Sanofi Aventis Company Information
  11.8.2 Sanofi Aventis Drugs for Malaria Product Offered
  11.8.3 Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Aventis Main Business Overview
  11.8.5 Sanofi Aventis Latest Developments
11.9 Ajanta Pharma
  11.9.1 Ajanta Pharma Company Information
  11.9.2 Ajanta Pharma Drugs for Malaria Product Offered
  11.9.3 Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Ajanta Pharma Main Business Overview
  11.9.5 Ajanta Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Drugs for Malaria Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drugs for Malaria Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aryl Aminoalcohol Compounds
Table 4. Major Players of Antifolate Compounds
Table 5. Major Players of Artemisinin Compounds
Table 6. Drugs for Malaria Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Drugs for Malaria Market Size byType (2020-2025) & ($ millions)
Table 8. Global Drugs for Malaria Market Size Market Share byType (2020-2025)
Table 9. Drugs for Malaria Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Drugs for Malaria Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Drugs for Malaria Market Size Market Share by Application (2020-2025)
Table 12. Global Drugs for Malaria Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Drugs for Malaria Revenue Market Share by Player (2020-2025)
Table 14. Drugs for Malaria Key Players Head office and Products Offered
Table 15. Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Drugs for Malaria Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Drugs for Malaria Market Size Market Share by Region (2020-2025)
Table 20. Global Drugs for Malaria Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Drugs for Malaria Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Drugs for Malaria Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Drugs for Malaria Market Size Market Share by Country (2020-2025)
Table 24. Americas Drugs for Malaria Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Drugs for Malaria Market Size Market Share byType (2020-2025)
Table 26. Americas Drugs for Malaria Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Drugs for Malaria Market Size Market Share by Application (2020-2025)
Table 28. APAC Drugs for Malaria Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Drugs for Malaria Market Size Market Share by Region (2020-2025)
Table 30. APAC Drugs for Malaria Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Drugs for Malaria Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Drugs for Malaria Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Drugs for Malaria Market Size Market Share by Country (2020-2025)
Table 34. Europe Drugs for Malaria Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Drugs for Malaria Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Drugs for Malaria Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drugs for Malaria Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Drugs for Malaria Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Drugs for Malaria
Table 40. Key Market Challenges & Risks of Drugs for Malaria
Table 41. Key IndustryTrends of Drugs for Malaria
Table 42. Global Drugs for Malaria Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Drugs for Malaria Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Drugs for Malaria Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Drugs for Malaria Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Cipla Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 47. Cipla Drugs for Malaria Product Offered
Table 48. Cipla Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Cipla Main Business
Table 50. Cipla Latest Developments
Table 51. Guilin Pharmaceutical Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 52. Guilin Pharmaceutical Drugs for Malaria Product Offered
Table 53. Guilin Pharmaceutical Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Guilin Pharmaceutical Main Business
Table 55. Guilin Pharmaceutical Latest Developments
Table 56. IPCA Laboratories Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 57. IPCA Laboratories Drugs for Malaria Product Offered
Table 58. IPCA Laboratories Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. IPCA Laboratories Main Business
Table 60. IPCA Laboratories Latest Developments
Table 61. GlaxoSmithKline Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 62. GlaxoSmithKline Drugs for Malaria Product Offered
Table 63. GlaxoSmithKline Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Latest Developments
Table 66. Mylan Labs Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 67. Mylan Labs Drugs for Malaria Product Offered
Table 68. Mylan Labs Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Mylan Labs Main Business
Table 70. Mylan Labs Latest Developments
Table 71. Roche Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 72. Roche Drugs for Malaria Product Offered
Table 73. Roche Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Roche Main Business
Table 75. Roche Latest Developments
Table 76. Novartis Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 77. Novartis Drugs for Malaria Product Offered
Table 78. Novartis Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Sanofi Aventis Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 82. Sanofi Aventis Drugs for Malaria Product Offered
Table 83. Sanofi Aventis Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sanofi Aventis Main Business
Table 85. Sanofi Aventis Latest Developments
Table 86. Ajanta Pharma Details, CompanyType, Drugs for Malaria Area Served and Its Competitors
Table 87. Ajanta Pharma Drugs for Malaria Product Offered
Table 88. Ajanta Pharma Drugs for Malaria Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Ajanta Pharma Main Business
Table 90. Ajanta Pharma Latest Developments



LIST OFFIGURES

Figure 1. Drugs for Malaria Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Malaria Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drugs for Malaria Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drugs for Malaria Sales Market Share by Country/Region (2024)
Figure 8. Drugs for Malaria Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drugs for Malaria Market Size Market Share byType in 2024
Figure 10. Drugs for Malaria in Prevention
Figure 11. Global Drugs for Malaria Market: Prevention (2020-2025) & ($ millions)
Figure 12. Drugs for Malaria inTreatment
Figure 13. Global Drugs for Malaria Market:Treatment (2020-2025) & ($ millions)
Figure 14. Drugs for Malaria in Others
Figure 15. Global Drugs for Malaria Market: Others (2020-2025) & ($ millions)
Figure 16. Global Drugs for Malaria Market Size Market Share by Application in 2024
Figure 17. Global Drugs for Malaria Revenue Market Share by Player in 2024
Figure 18. Global Drugs for Malaria Market Size Market Share by Region (2020-2025)
Figure 19. Americas Drugs for Malaria Market Size 2020-2025 ($ millions)
Figure 20. APAC Drugs for Malaria Market Size 2020-2025 ($ millions)
Figure 21. Europe Drugs for Malaria Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Drugs for Malaria Market Size 2020-2025 ($ millions)
Figure 23. Americas Drugs for Malaria Value Market Share by Country in 2024
Figure 24. United States Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Drugs for Malaria Market Size Market Share by Region in 2024
Figure 29. APAC Drugs for Malaria Market Size Market Share byType (2020-2025)
Figure 30. APAC Drugs for Malaria Market Size Market Share by Application (2020-2025)
Figure 31. China Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 35. India Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Drugs for Malaria Market Size Market Share by Country in 2024
Figure 38. Europe Drugs for Malaria Market Size Market Share byType (2020-2025)
Figure 39. Europe Drugs for Malaria Market Size Market Share by Application (2020-2025)
Figure 40. Germany Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 41.France Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Drugs for Malaria Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Drugs for Malaria Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Drugs for Malaria Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Drugs for Malaria Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 54. APAC Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 55. Europe Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 57. United States Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 58. Canada Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 59. Mexico Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 60. Brazil Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 61. China Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 62. Japan Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 63. Korea Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 65. India Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 66. Australia Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 67. Germany Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 68.France Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 69. UK Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 70. Italy Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 71. Russia Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 72. Egypt Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 73. South Africa Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 74. Israel Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 75.Turkey Drugs for Malaria Market Size 2026-2031 ($ millions)
Figure 76. Global Drugs for Malaria Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Drugs for Malaria Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Drugs for Malaria Market Size 2026-2031 ($ millions)